0153 GMT - Hong Kong's Hang Seng Index falls 1.1% to 22692.06, weighed by tech stocks. Tech stocks may be facing profit-taking amid concerns about President Trump's new 25% tariff threats on some goods, the Saxo APAC research team writes in a commentary. Even though Beijing has established a pro-tech stance, there are some doubts about the recent Chinese stock rally, they add. Among the biggest decliners on the benchmark index, Kuaishou Technology loses 4.1%, Alibaba Group is 2.8% lower and Tencent falls 2.3%. Meituan sheds 5.4%. Health-related stocks lead the gains, with WuXi AppTec up 3.1%, Alibaba Health Information Technology adding 2.8% and CSPC Pharmaceutical Group rising 2.7%. (kimberley.kao@wsj.com)
(END) Dow Jones Newswires
0153 GMT - Hong Kong's Hang Seng Index falls 1.1% to 22692.06, weighed by tech stocks. Tech stocks may be facing profit-taking amid concerns about President Trump's new 25% tariff threats on some goods, the Saxo APAC research team writes in a commentary. Even though Beijing has established a pro-tech stance, there are some doubts about the recent Chinese stock rally, they add. Among the biggest decliners on the benchmark index, Kuaishou Technology loses 4.1%, Alibaba Group is 2.8% lower and Tencent falls 2.3%. Meituan sheds 5.4%. Health-related stocks lead the gains, with WuXi AppTec up 3.1%, Alibaba Health Information Technology adding 2.8% and CSPC Pharmaceutical Group rising 2.7%. (kimberley.kao@wsj.com)
(END) Dow Jones Newswires
February 19, 2025 20:54 ET (01:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.